Ipsen Biopharmaceuticals, Inc.
Lobbying group · Jul 2025 – Sep 2026
Ipsen Biopharmaceuticals, Inc. spent $300K lobbying the federal government (Jul 2025 – Sep 2026), mostly on taxes, medicare & medicaid. It used 2 lobbyists, including people who worked for 2 members of Congress.
- Spent on lobbying
- $300K
- Lobbyists
- 2
- Issues
- 2
Spending by quarter
- 2025 Q3$70K
- 2025 Q4$70K
- 2026 Q1$70K
- 2026 Q2$70K
- 2026 Q3$20K
Issues lobbied
- Taxes
- Medicare & Medicaid
Lobbying firms hired
- Capitol Counsel LLC$120K
- Holland & Knight LLP$100K
- W Strategies, LLC$80K
Lobbyists who worked in Congress
- Andrew Siracuse
Sr. Tax Cnsl., Sen. John Cornyn; Staff Dir., Sen. Fin. Cmte. Int'l. Trade, Customs & Global Comp. Sbcmte., Tax Cnsl…John Cornyn (R-TX) - John Martin
Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton…Tom Cotton (R-AR)
Agencies contacted
- Senate · 13
- House Of Representatives · 9
Related
Filings
- 2026 Q3 report$20K
- 2026 Q2 report$30K
- 2026 Q2 report$20K
- 2026 Q2 report$20K
- 2026 Q1 report$20K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Ipsen Biopharmaceuticals, Inc.: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cipsenbiopharmaceuticals/ipsen-biopharmaceuticals-inc (accessed 2026-10-17).